Status:

RECRUITING

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Lead Sponsor:

Christopher Dvorak

Conditions:

Graft Vs Host Disease

Graft-versus-host-disease

Eligibility:

All Genders

Up to 30 years

Phase:

NA

Brief Summary

Patients in need of an allogeneic hematopoietic cell transplant (HCT) are at risk of developing graft-versus-host-disease (GVHD). In certain clinical situations, the optimal approach to minimize the r...

Detailed Description

The original CliniMACS® device (CD34 Reagent System) employs a reagent consisting of an antibody that specifically binds to blood cells that express the CD34+ surface marker (hematopoietic stem cells ...

Eligibility Criteria

Inclusion

  • Male or female 0-30 years of age at time of transplant admission
  • Documentation of a disease requiring HCT
  • A donor (mismatched related or unrelated) must be located who are healthy and willing, and whom are able to donate bone marrow (BM) or peripheral blood stem cells (PBSC). Matched related donors may be used for patients with Fanconi Anemia.
  • Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study

Exclusion

  • Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
  • Presence of a healthy and willing HLA-identical related donor (except when the patient has Fanconi Anemia).
  • Patient with an anticipated life expectancy of \<1 month
  • Patients with known hypersensitivity to murine (mouse) proteins or iron dextran

Key Trial Info

Start Date :

December 19 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2035

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04337515

Start Date

December 19 2019

End Date

January 1 2035

Last Update

March 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94143

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant | DecenTrialz